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annot be prevented.9,10 AD is a speciﬁc complication in
atients with medullary injury that can involve risk of death,
herefore a hypertensive crisis must be known and suspected
f in this group of patients. Its management will be focused on
ts detection and avoiding the triggering cause of hypertensive
risis.
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ear Editor,
atients with chronic renal failure may present multiple cuta-
eous manifestations such as pruritus, xerosis, cutaneous
igmentation, metastatic calcinosis cutis, calciphylaxis, pseu-
oporphyria and late cutaneous porphyria. Grover’s disease
GD) must also be included in the differential diagnosis of
utaneous lesions in these patients.
We are presenting a case of a 69-year-old woman who pre-
ented with one and a half moth of cutaneous lesions in the
ackwithmoderate itching. Shehadnopersonal or family his-
ory of skin pathology. She had been receiving haemodialysis
or ﬁvemonths due toGoodpasture syndrome induced rapidly
rogressive renal failure. During the previous months, she
ad been treated with plasmapheresis, IV cyclophosphamide
nd IV methylprednisolone. At the time of consultation, her
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treatment included prednisone 5mg/day, calcitriol
0.25mg/day, omeprazol 20mg/day, enoxaparin sodium
20mg 3days/week and darbepoetin alfa 30mcg weekly. Phys-
ical examination shows non-conﬂuent papular erythematous
lesions with keratotic surface, located in the back (Fig. 1a).
She did not have lesions on palms or soles, back of the hands
or the oral mucosa. She did not have a facial or scalp lesions
either. Microscopic evaluation showed areas of hyperkeratosis
with parakeratosis, acanthosis and focal acantholysis with
presence of round and granular lesions (Fig. 1b). Taking into
account the almost asymptomatic character of the lesions,
the patient preferred to adopt an expectant attitude. Three
months later, the lesions disappeared spontaneously. The
absence of a previous family history, the onset at an adult
age, and the spontaneous resolution of the symptoms led toez-Vilas D, Durana C. Enfermedad de Grover en fracaso renal
the diagnosis of GD.
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Fig. 1 – (a) Aspect of the skin lesions: non-conﬂuent brownish keratotic papules. (b) Areas of focal acantholysis
rwith dyskeratosis (H&E, 200×).
Discussion
GD, also known as persistent or transient acantholytic der-
matosis, is a rare condition characterised by the presence
of small papules and papulo-vesicles, of the same color as
normal skin or erythematous and pruritic, which usually
affect the back. The disease is usually transient and resolves
spontaneously within weeks. In some cases, lesions may
be recurrent or persist throughout years. The histological
changes are characterized by focal acantholysis and dysker-
atosis. Four histological patterns have been identiﬁed: Darier
type, Haley–Haley type, pemphigus and spongiotic type.1
The aetiology of GD is unknown. Fever or prolonged
bed rest, sweating or excessive heat, exposure to UV radia-
tion, treatment with ionizing radiations, xerosis, some drugs,
chronic renal failure and immunosuppressionhave been asso-
ciated with this disease.2
To date, including our case, there has been twelve cases
published of GDassociated tochronic renal failure (Table 1).3–10
The mean age has been 57 years and, except for two cases,
all of them were men. The normal presentation was kera-
totic, pruritic papules located in the back. In three cases, the
lesions were asymptomatic.4,6 The head was affected in four
patients3–5,9 and in one of them it was the only location.3 The
cause of renal failure was variable. In eleven cases the lesions
appeared when the patient on regular haemodialysis (7 cases)
or peritoneal dialysis (3 cases) and in one case the disease
manifested itself after kidney transplant. The mean time from
the beginning of dialysis until the appearance of the lesions
varied from months to eight and a half years. The most fre-
quent histopathological patternwas theDarier type. Evolution
was variable and there is a poor response to the treatment. In
seven cases the lesions were transient and in ﬁve persisted.
Among patients with transient lesions, in three cases resolved
spontaneously,4,7 in one after treatment,9 in two cases the
4,8lesions reoccur after kidney transplant and in one patient
they resolved after changing the dialysis solution.10
Although the reason why GD appears in patients with
chronic renal failure is unknown, it has been stated thatthe decrease in sweat secretion, cutaneous xerosis and the
obstruction of sweat ducts may act as triggering factors. In our
patient, the treatment with cyclophosphamide and methyl
prednisolone previously administered in order to treat her
kidney disease could also have played a role in the devel-
opment of the lesions. The association of GD with other
states of immunosuppression„ such as HIV infection, bone
marrow transplant, and several haematological and non-
haematological malignancies has been described.
With respect to treatment, in the mildest cases, an
expectant attitude can be adopted since the disease usually
resolves spontaneously. Sun exposure and other triggering
factors such as physical exercise and heat should be avoided.
If treatment is necessary, corticosteroids, calcipotriol, or
calcineurin inhibitors may be used topically as the ﬁrst-line
of drugs. Antihistamines should be used to reduce symp-
toms. For refractory cases, corticosteroids, oral retinoids and
phototherapy can been used.
GD should be taken into account in the differential diag-
nosis of the cutaneous lesions in patients with chronic renal
failure, speciﬁcally in those patients on haemodialysis or per-
itoneal dialysis.
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Table 1 – Grover cases of chronic renal failure disease reported in literature.
Cases Age Gender Renal disease Type of dialysis Time since
dialysis
Clinical symptoms Location Pruritus Histological
pattern
Progress
1 Chua and Giam,3
1997
53 M Chronic GN Haemodialysis 8.5 years Papules Retroarticular
and neck
Y Darier Persistent
2 Casanova et al.,4
1999
39 M Chronic GN Haemodialysis 3 months Keratotic papules Face and torso Y Darier Persistent
3 Casanova et al.,4
1999
75 M Hypertensive
nephropathy
Haemodialysis 6 months Keratotic papules Torso and
extremities
N Darier Persistent
4 Casanova et al.,4
1999
35 M Chronic pyelonephritis Haemodialysis 13 months Keratotic papules
and
papulovesicles
Torso Y Spongiotic Resolution after
transplant
5 Casanova et al.,4
1999
44 M Chronic GN Haemodialysis 2 months Keratotic papules Torso N Darier Spontaneous
resolution
6 Wong and Chua,5
2000
70 M NS Peritoneal
dialysis
6 months NS Torso and head Y Darier Persistent
7 Pastor et al.,6
2003
69 M Urothelial carcinoma
(nephrectomy)
Haemodialysis 2 months Keratotic papules Torso and
extremities
N Darier Persistent
8 Boutli et al.,7
2006
58 M Membranous GN None
(transplanted)
– Papules Torso Y Darier Spontaneous
resolution
9 González-Sixto
et al.,8 2007
62 M Chronic GN Peritoneal
dialysis
32 months Papules Torso Y Darier Resolution after
transplant
10 Bassi et al.,9 2012 43 F Membranoproliferative
GN
Haemodialysis NS Keratotic papules Torso,
extremities and
scalp
Y Darier Resolution with
treatment
11 Jatem et al.,10
2013
68 M Polycystic kidney Peritoneal
dialysis
6 months Maculo-papules Torso and
extremities
Y Darier Resolution upon
substituting
dialysis solution
12 Our case 69 F Rapidly progressive GN Haemodialysis 5 months Keratotic papules Torso Y Darier Spontaneous
resolution
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Severe arrhythmia due to hyp
from diuretic substances
Arritmia cardiaca grave por hipopo
sustancias diuréticas
Dear Editor,
This was a case of a 25-year-old woman with no known aller-
gies or relevant medical history and no toxic habits. She is an
attorney and drinks 500–750ml of beverages containing tau-
rine and 1 l of caffeinated soda per day due to stress. The fol-
lowing details were observed: height 170 cm, weight 58kg and
BMI 20. She was admitted to the hospital for headache
and tachycardia during the last two days after she did some
sports and coinciding with an increase in the consumption
of a beverages containing taurine. She denied chest pain or
dyspnoea. Had no vomiting or diarrhoea and had no change
in diuresis. She did not consume herbal products, drugs,
teas, diuretics, liquorice or alcohol. Physical examine: Con-
scious, oriented, blood pressure 108/86, heart rate 110 beats
per minute. Afebrile. Anodyne cardiopulmonary auscultation.
Rest of the examination was normal. Blood test: normal red cell
count, no elevation of cardiac or hepatic enzymes and coag-
ulation test without alterations; creatinine 1.04mg/dL, urea
31mg/dL, potassium 1.73mEq/L, sodium 134mEq/L, magne-
sium 2.2mg/dL, chloride 85mEq/L, Albumin 4g/dL. Arterial
blood gas: Ph 7.580, PCO2 46mmHg, PO2 86mmHg, bicarbonate
43.1mmol/L. Plasma anion gap (AG): 5.9mEq/L. Urine: chloride
22.2mEq/L, potassium 68.28mEq/L, sodium 210mmol/L, urea
920mg/dL, creatinine 192.72mg/dL, glucose 15mg/dL. Urine
anion gap: 256mEq/L. Plasma osmolality: 278.2mOsm/L.
Urine osmolality: 573.3mOsm/l. Transtubular potassium
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alemia. Inﬂuence
semia. Inﬂuencia de las
gradient: 15. Cortisol at 8 am and aldosterone in supine
position were within the normal range. No alterations in uri-
nary sediment. ECG: sinus rhythm, markedly enlarged QT
(580ms; corrected 700ms); with frequent polymorphic ven-
tricular tachycardia (Fig. 1). An infusion of CLK was initiated
via central line: 80mEq within two hours and maintained with
an infusion of 120mEq/day. After 18h, urine test was: sodium
25.3mEq/L, potassium6.2mEq/L; in serum: sodium142mEq/L,
potassium 2.8mEq/L transtubular potassium gradient: 4.
Venous blood gas: Ph 7.380, PCO2 52mmHg, HCO3 30.8. Blood
test at discharge: sodium 143mEq/L, potassium 4.84mEq/L,
chloride 105m Eq/L, pH 7.380, pCO2 49mmHg, bicarbon-
ate 29mmol/L. Urine: potassium 11.59mmol/L, sodium
89mmol/L, creatinine 266.27mg/dL, urea 642mg/dL. The ECG
was normal. The evolution of ions in the urine suggested
the presence of a diuretic substance that was suspended
at admission. Diagnoses: hypokalaemia due to diuretic sub-
stances: taurine and caffeine, but not being able to rule out
the presence of other diuretics, aggravated by the increase of
insensitive losses and alkalemic state. A Bartter vs Gitelman-
type tubulopathy was ruled out given the evolution of the ions
in urine and the hormonal axis normality. Alteration in heart
conduction due to hypokalaemia.Mixed alkalaemia: Chloride-
resistant metabolic alkalosis due to diuretic substances anderto-Blazquez L, Sanchez-Tomero JA. Arritmia cardiaca grave por
5;35:334–336.
reactive respiratory alkalosis.
Ninety percent of the potassium ﬁltered at glomerular level
is reabsorbed in the proximal tube. The distal tubule, by effect
